TAAT Announces Shares for Debt Settlement

Apr 19, 202421:05 UTC

(TheNewswire)

LAS VEGAS and VANCOUVER, April 19, 2024 –TheNewswire – TAAT®GLOBAL ALTERNATIVES INC. TAAT TOBAF (FRANKFURT: 2TP)(the “Company” or “TAAT®”) announces that it has entered intoa debt settlement agreement (the “Settlement Agreement”) to fully settle outstanding debts owed to a creditor(the “Creditor”) for corporate back-office services rendered. Pursuant tothe Settlement Agreement, the Company has agreed to issue an aggregateof 303,456 common shares (“Shares”) at a deemed price of $0.265 perShare, based on a 20-day VWAP (the “Share Settlement”).

The Company anticipates closing the Share Settlement onor about April 26, 2024. The Share Settlement will settle $80,415.88in debts owed to the Creditor, which is a full settlement for thetotal amount of bona fide debts owed to the Creditor.

The board of directors of the Company has determinedthat it is in the best interests of the Company to settle theoutstanding debts by the issuance of the Shares in order to preservethe Company's cash for working capital.

The Company will be relying on the “Employee,Executive Officer, Director and Consultant” exemption contained insection 2.24 (the “Exemption”) of National Instrument 45-106 -Prospectus Exemptions, to issue the Shares to the Creditor. TheCanadian Securities Exchange has waived the requirement to impose a 4month and one day hold period on the Shares.

On behalf of the Board of Directors of theCompany,

TAAT® GLOBAL ALTERNATIVES INC.

“Michael Saxon”

Michael Saxon, CEO and Director

For further information, please contact:

TAAT® Investor Relations

1-833-TAAT-USA (1-833-822-8872)

investor@taatglobal.com

THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOTREVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY ORADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATIONSERVICES PROVIDER.

About TAAT® Global Alternatives Inc.

TAAT® is a vertically integrated consumer product anddistribution company, generating more than CAD $90 million in overallgross revenue annually. TAAT® is strategically expanding its productcategories including tobacco and reduced-risk alternatives, hemp,kratom, and other emerging CPG segments. TAAT® has facilities toinclude a processing plant in Nevada as well as a distribution centrein Canton, Ohio, leveraging existing retail shelf space and pipelinesinto national wholesale channels.

For more information, please visit http://taatglobal.com.

Forward-Looking Statements

Certain information contained herein may constitute"forward-looking information" or "forward-lookingstatements" under Canadian securities legislation. Generally,forward-looking information can be identified by words such as"pro forma", "plans", "expects","may", "should", "could","will", "budget", "scheduled","estimates", "forecasts", "intends","anticipates", "believes", or variations includingnegative variations thereof of such words and phrases that refer tocertain actions, events or results that may, occur or be taken orachieved. Such forward-looking statements, including but not limitedto statements relating to the expected development and operations ofthe Company, statements concerning the timing, review, completion andfiling of the Annual Filings as well as the duration of the MCTO,involve risks, uncertainties and other factors which may cause theactual results to be materially different from those expressed orimplied by such forward-looking statements or forward-lookinginformation. There can be no assurance that such statements will proveto be accurate, as actual results and future events could differmaterially from those anticipated in such statements. Accordingly,readers should not place undue reliance on forward-looking statementsand forward-looking information. The Corporation will not update anyforward-looking statements or forward-looking information includedherein, except as required by applicable securities laws.

The statements in this news release have not beenevaluated by Health Canada or the U.S. Food and Drug Administration.As each individual is different, the benefits, if any, of taking theCompany’s products will vary from person to person. No claims orguarantees can be made as to the effects of the Company’s productson an individual’s health and well-being. The Company’s productsare not intended to diagnose, treat, cure, or prevent anydisease.

This news release may contain trademarked names ofthird-party entities (or their respective offerings with trademarkednames) typically in reference to (i) relationships had by the Companywith such third-party entities as referred to in this release and/or(ii) client/vendor/service provider parties whose relationship withthe Company is/are referred to in this release. All rights to suchtrademarks are reserved by their respective owners orlicensees.

Statement Regarding Third-Party Investor RelationsFirms

Disclosures relating to investor relations firmsretained by TAAT® Global Alternatives Inc. can be found under theCompany's profile on http://sedarplus.ca.